Charles Cox

2.1k citations
19 papers · 1.3k indexed · h-index 17
Topics
Chronic Lymphocytic Leukemia Research (4 papers)Mycobacterium research and diagnosis (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)

In The Last Decade

Charles Cox

19 papers receiving 1.3k citations

Peers

Charles Cox
Comparison fields: 5 of 105
  • Immunology 328
  • Molecular Biology 283
  • Genetics 246
  • Pharmacology 241
  • Rheumatology 198
Replace Surakameth Mahasirimongkol with:
Surakameth Mahasirimongkol Thailand
N J Fitch United Kingdom
D. Sayer Australia
A. Martin Australia
Christine Lonjou United Kingdom
Rui M. M. Victorino Portugal
Nicole A. Mifsud Australia
E P Sampaio Brazil
Lyoung Hyo Kim South Korea
M. Hart Netherlands
Charles Cox relative to Surakameth Mahasirimongkol Thailand Surakameth Mahasirimongkol's profile →
Citations per field
00.5×
Surakameth Mahasirimongkol · 1×
Citations per year

Countries citing papers authored by Charles Cox

Since Specialization
Citations

This map shows the geographic impact of Charles Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Cox more than expected).

Fields of papers citing papers by Charles Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Cox. The network helps show where Charles Cox may publish in the future.

Co-authorship network of co-authors of Charles Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Cox. A scholar is included among the top collaborators of Charles Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Cox. Charles Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 32
2 106
3 45
4 4
5 61
6 245
7 125
8 18
9 199
10 1
11 85
12 20
13 61
14 17
15 65
16 39
17 16
18 94
19 67

About Charles Cox

Charles Cox is a scholar working on Genetics, Pharmacology and Parasitology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Mycobacterium research and diagnosis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pharmacology (241 citations), Immunology (328 citations) and Rheumatology (198 citations). Charles Cox has collaborated with scholars based in United Kingdom, United States and Portugal. Frequent co-authors include Matthew R. Nelson, Judong Shen, Alexander Dilthey, Gil McVean, Margaret G. Ehm, Xiuwen Zheng, J. C. Wakefield, B. S. Weir, Karen S. King and Colin F. Spraggs. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026